Last reviewed · How we verify

red blood cells autotransfusion

Michał Stasiowski · Phase 1 active Biologic

red blood cells autotransfusion is a Biologic drug developed by Michał Stasiowski. It is currently in Phase 1 development. Also known as: cell saver.

At a glance

Generic namered blood cells autotransfusion
Also known ascell saver
SponsorMichał Stasiowski
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about red blood cells autotransfusion

What is red blood cells autotransfusion?

red blood cells autotransfusion is a Biologic drug developed by Michał Stasiowski.

Who makes red blood cells autotransfusion?

red blood cells autotransfusion is developed by Michał Stasiowski (see full Michał Stasiowski pipeline at /company/micha-stasiowski).

Is red blood cells autotransfusion also known as anything else?

red blood cells autotransfusion is also known as cell saver.

What development phase is red blood cells autotransfusion in?

red blood cells autotransfusion is in Phase 1.

Related